Drugs / CsA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00065260 | Nov 2003 → Dec 2010 | aplastic anemia | National Heart, Lung, and Blood Institute (NHLBI) | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CsA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00065260 ↗ |
| Route | Oral | “CsA 10mg/kg/day orally twice daily for 6 months (15mg/kg/day for children under 12 yrs.” NCT00065260 ↗ |